Apostle is a provider of technologies and services for public health and life sciences. Our innovations feature Apostle MagTouch Nucleic Acids Isolation Automation System, Apostle MiniMax cfDNA technologies (see Science), and others.

Our response to help our community fight COVID-19 together: High Quality*, Low Cost**, Fast #, Safe ##, Apostle COVID-19 Viral RNA Isolation Automation System, supported by a strong and stable global supply chain.

Over 2 million samples processed. Clinically validated. (Download Application Note)

* Equal or better results compared with other brands. ** Guaranteed 30% - 50% less cost than other brands. # Run time is approximately 40 minutes per 96 samples. Approximately 2,500 samples per unit per 24 hours. ## Integrated with a UV light for unit interior disinfection.

Apostle MagTouch 1000 System


News


2020
Oct
1
Apostle Inc releases an Application Note on the Apostle COVID-19 Viral RNA Extraction System
Apostle Inc is pleased to release an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 1 million clinical samples by our clients. Using Apostle system, limit of Detection (LoD) of the downstream detection system of our customer is documented at 3.6 NDU/uL published on the FDA website. The sensitivity and specificity is 99.9% and 99.9% at 3 copies/uL, respectively, published on our customer’s website. read more
2020
Sept
7
Apostle Inc’s MiniEnrich Technology is Published at Royal Society of Chemistry’s Analyst
Apostle Inc is pleased to announce that the company’s original technology, termed the Apostle MiniEnrich Technology, is published at Royal Society of Chemistry’s Analyst on Sept 7, 2020, vol 145, issue 17, pp 5733-5739, and is selected as the inside front cover story. read more
2020
Sept
3
Apostle Inc Appoints Charles (Buck) Strom to Board of Advisors
Apostle Inc is pleased to announce the appointment of Charles (Buck) Strom, MD, PhD, FAAP, FACMG, HCLD, as a new member to its Board of Advisors. read more

Storyline